Topic
Next-Generation Sequencing (NGS)
3 Podcasts on BackTable
Episode # 74 • 28 Jul 2026
Systemic Therapy Strategies for Treating Neuroendocrine Tumors
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)? In this new episode of BackTable Tumor Board, Drs. Lingling Du, Chih-Yi Liao, and Robert Ramirez discuss the use of systemic or radioligand therapies for metastatic well-differentiated NETs.
This podcast is supported by
More on Next-Generation Sequencing (NGS)
Loading recent podcasts…
Tumor Board # 74
Jul 27, 2026
with Dr. Chih-Yi Liao, Dr. Robert Ramirez, Dr. Lingling Du
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)?...
Tumor Board # 41
Dec 29, 2025
with Dr. Shubham Pant, Dr. Jonathan Mizrahi
Metastatic pancreatic cancer is no longer a ‘one size fits all’ diagnosis. In this episode of the BackTable Tumor Board...
Tumor Board # 58
May 4, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.